Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 218 CNY -1.13% Market Closed
Market Cap: 131.5B CNY
Have any thoughts about
Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Wall Street analysts forecast Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 280.87 CNY with a low forecast of 176.75 CNY and a high forecast of 375.9 CNY.

Lowest
Price Target
176.75 CNY
19% Downside
Average
Price Target
280.87 CNY
29% Upside
Highest
Price Target
375.9 CNY
72% Upside
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors:
Price Targets
603998
Hunan Fangsheng Pharmaceutical Co Ltd
42% Upside
EMCURE
Emcure Pharmaceuticals Ltd
23% Upside
4016
Middle East Pharmaceutical Industries Company SJSC
10% Upside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
7% Downside
FAE
Faes Farma SA
18% Upside
SANOFI
Sanofi India Ltd
34% Upside
GLS
Glenmark Life Sciences Ltd
11% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 23%. The projected CAGR for the next 4 years is 16%.

23%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 4 years is 19%.

26%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 15%.

25%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's stock price target?
Price Target
280.87 CNY

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 280.87 CNY with a low forecast of 176.75 CNY and a high forecast of 375.9 CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 23%. The projected CAGR for the next 4 years is 16%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 4 years is 19%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 15%.

Back to Top